Navigation Links
PharmAthene Reports First Quarter 2013 Financial And Operational Results
Date:5/8/2013

ANNAPOLIS, Md., May 8, 2013 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the first quarter of 2013.

"We made steady progress in our biodefense programs this quarter," said Eric I. Richman , President and Chief Executive Officer. "We submitted to the U.S. Food and Drug Administration (FDA) our complete response to the SparVax® clinical hold notification and look forward to moving ahead soon.

"Regarding our chemical and nerve agent bioscavenger program, testing conducted by the U.S. Army Research Institute for Chemical Defense showed that our recombinant bioscavenger successfully targets and binds to a broad spectrum of nerve agents, including sarin and tabun.  These agents are believed to be part of the Syrian chemical weapons inventory.  If successful, we believe that our recombinant bioscavenger could provide a more cost-effective solution to address the threat of chemical weapons."

Linda L. Chang , Senior Vice President and Chief Financial Officer, commented, "We are off to a good start in 2013 meeting our financial objectives, including achieving neutral to slightly positive cash flow in the first quarter.  For the year, we anticipate relatively low cash usage overall, consistent with the capital-efficient nature of our government contracting business model."

Additionally, oral arguments on the appeal of the May 2012 Delaware Court of Chancery final order and judgment, awarding PharmAthene a significant economic interest in SIGA Technologies' smallpox antiviral, Arestvyr™, were heard in the Delaware Supreme Court in the first quarter.  The Company anticipates a ruling by the Supreme Court on the appeal could occur by the end of the
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
2. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
3. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
4. Sangamo BioSciences Reports First Quarter 2013 Financial Results
5. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
6. Halozyme Reports First Quarter 2013 Financial Results
7. Depomed Reports First Quarter 2013 Financial Results
8. InspireMD Reports Financial Results For Period Ended March 31, 2013
9. Isis Reports Financial Results and Highlights for First Quarter 2013
10. Perrigo Reports Record Revenue and Adjusted Earnings
11. Discovery Labs Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015   Voalte , the ... capital infusion of $17 million by Ascension Ventures ... and Bedford Funding. Series D funding closed on July ... to nearly $60 million in three years. ... triple-digit growth trajectory for Voalte. The privately held company ...
(Date:9/1/2015)... 2, 2015 The latest ... clinical trials review of H2, 2015 provides an ... objective to enhance decision making capabilities of active ... on Keratoconus market clinical trials review spread across ... / government organizations and supported with 43 tables ...
(Date:9/1/2015)... Australia and Delaware , ... Invion Limited (ASX: IVX; "Company" or "Invion"), is pleased to ... the following securities to an institutional investor in ... aggregate gross proceeds of approximately A$1.001 million ("Placement") by the ... issue price of $0.014 per share. The ...
Breaking Medicine Technology:Voalte Raises $17 Million in Series D Financing 2Voalte Raises $17 Million in Series D Financing 3Voalte Raises $17 Million in Series D Financing 4Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 2Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 3Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 4Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 5Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3
... 6, 2011 The Center for Business Intelligence (CBI) ... Drug Development being held February 23, 2011 from 9:30 ... opportunity to bring together a diverse collection of imaging ... latest imaging technologies relevant to today,s practitioners in a ...
... CITY, Jan. 6, 2011 Altheus Therapeutics, Inc., announced ... Phase I clinical trial of the safety and tolerability ... or distal, ulcerative colitis.  No serious adverse events were ... to have achieved this milestone, as it prepares Altheus ...
Cached Medicine Technology:The Center for Business Intelligence (CBI) Announces Virtual Conference on Imaging for Drug Development 2Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis 2
(Date:9/2/2015)... ... , ... Every year at this time, students prepare to go back to ... face the academic workload confronting them. They just don’t have the skills needed to ... teach students how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... announces Hand Free Pocket Cop, a safety invention that protects people from crime ... worth $31 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:9/2/2015)... ... , ... Ovarian cancer continues to be the deadliest of all gynecologic cancers. ... her lifetime is approximately 1 in 75. This year it is estimated that approximately ... , There is no test to detect ovarian cancer. A Pap test does ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream ... cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for intense ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, a North Carolina ... Inc. 5000 List, an independent ranking of the fastest- growing private companies ... this achievement puts Canopy in rarefied company. Over the years, this elite group ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2
... groups were thought to be rare, but recent studies ... the thin beauty ideal. As a result, experts expect ... ethnic groups. It is also suspected that eating disorders ... boys. Although research has shown that eating disorders ...
... of the Charmin Restrooms to ... Times Square This Holiday Season, NEW YORK, Nov. ... free, fully-staffed public restrooms,in New York City as the Charmin(R) Restrooms ... Shannon will inaugurate the stalls,with the ceremonial "first flush" and ribbon ...
... Family Caregiver,s Month; Announces Availability ... More than 34 Million Caregivers, PALO ALTO, Calif., Nov. ... proud to support the more than 34 million,Americans caring for ... availability of its website. Designed to give caregivers the ...
... Flow Cytometry Portfolio Targeted at Fast Growing ... ... Nov. 19, Beckman Coulter, Inc. (NYSE: BEC ), a leading,developer ... A/S, a world leader in cancer diagnostics,announced today that Beckman Coulter ...
... REDWOOD CITY, Calif., Nov. 19 People grow ... is no different. SleepQuest, the leader in,at-home diagnostic ... growing pains which accompany rapid growth by moving ... INC. Magazine,s 5000 Fastest Growing Private,Companies in America, ...
... GNC is joining St. Jude Children,s,Research Hospital as ... is the fourth year for the national campaign and ... in the effort. Thanks and Giving was created ... Thomas and her siblings, Terre and Tony,Thomas, the children ...
Cached Medicine News:Health News:Eating disorders in adolescents 2Health News:Eating disorders in adolescents 3Health News:Video: Charmin's Gift That Keeps on Giving! 2Health News:Resource to Help Care for Aging Parents Now Available Nationwide 2Health News:Resource to Help Care for Aging Parents Now Available Nationwide 3Health News:Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako 2Health News:Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako 3Health News:SleepQuest Continues Growth, Moves Headquarters 2Health News:GNC Joins St. Jude Children's Research Hospital(R) to Kick Off Fourth Annual Thanks And Giving(R) Campaign, Asking America to Help Save Children's Lives While Shopping for the Holidays 2Health News:GNC Joins St. Jude Children's Research Hospital(R) to Kick Off Fourth Annual Thanks And Giving(R) Campaign, Asking America to Help Save Children's Lives While Shopping for the Holidays 3
Expressions lets you change your eye color with lenses that offer incredible comfort and outstanding vision quality. Expression color lenses use a technologically advanced tinting process to produce ...
Modern, innovative and quick Intense Pulsed Light system. The Flash 1 is light and very compact, thus easily portable. Available in two different colors....
... for the physician who wishes to offer ... of clinical applications. The innovative cooled Nd:YAG ... treaent of deeper lying veins. The IPL ... and pigmented lesions, including IPL Skin Treaents ...
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
Medicine Products: